Japanese phase III trial of prasugrel in patients with ischaemic stroke

Trial Profile

Japanese phase III trial of prasugrel in patients with ischaemic stroke

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Mar 2013

At a glance

  • Drugs Prasugrel (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 14 Mar 2013 This trial is ongoing and is expected to complete in the Japanese fiscal year (1 April to 31 March) 2014, according to a Daiichi Sankyo Company media release.
    • 03 Feb 2012 New trial record
    • 31 Jan 2012 The trial is expected to complete between fiscal year (31 March) 2013 and fiscal year 2014, according to a Daiichi Sankyo Company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top